ACADIA Pharmaceuticals Inc. (ACAD) Tuesday said first-quarter loss narrowed to $6.1 million or $0.08 per share from $6.2 million or $0.12 per share in the comparable quarter last year.
On average, nine analysts polled by Thomson Reuters expected the company to report a loss of $0.08 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $417 thousand, down from $450 thousand last year. Analysts expected revenues of $450 thousand.
Operating expenses decreased to $6.58 million from $6.68 million last year.
For comments and feedback: editorial@rttnews.com